Fortigel testosterone: Completed Phase III enrollment

ProStrakan completed enrollment of 140 patients in the open-label, U.S. Phase III Fortify trial. The company licensed worldwide rights to Fortigel from Cellegy (see BioCentury, Dec. 4, 2006). ...